IMURAN Side Effects

7003700-2 | Convulsion, Reversible Posterior Leukoencephalopathy Syndrome, Urinary Tract Infection
on Sep 03, 2010 Female patient from UNITED STATES , child 12 years of age, was diagnosed with colitis ulcerative and was treated with Imuran (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, reversible posterior leukoencephalopathy syndrome, urinary tract infection (What is urinary tract infection?). Imuran dosage: . During the same period patient was treated with ELESTAT (View Elestat Review and Elestat Label ).

7002930-3 | Balanitis, Blood Amylase Decreased, Blood Bicarbonate Increased, Blood Chloride Decreased, Blood Glucose Increased, Blood Triglycerides Increased, Lymphocyte Percentage Increased, Neutrophil Percentage Increased, Prostate Cancer
Patient was taking Imuran (View Usage). Patient had the following side effects: balanitis, blood amylase decreased, blood bicarbonate increased, blood chloride decreased, blood glucose increased, blood triglycerides increased, lymphocyte percentage increased, neutrophil percentage increased, prostate cancer (What is prostate cancer?) on Sep 02, 2010 from UNITED STATES Additional patient health information: Male patient , 71 years of age, was diagnosed with idiopathic pulmonary fibrosis and. Imuran dosage: 50 Mg;tid. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), METOLAZONE (View Metolazone Review and Metolazone Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

7001552-8 | No Adverse Event
Adverse event was reported on Sep 03, 2010 by a Male patient taking Imuran (View Usage) (Dosage: ) was diagnosed with colitis ulcerative and. Location: UNITED STATES , 27 years of age, After Imuran was administered, patient had the following side effects: no adverse event. During the same period patient was treated with CIMZIA (400 Mg; 1x Month; Sc) (View Cimzia Review and Cimzia Label ). Patient was hospitalized.

6965005-5 | Abdominal Pain, Anaemia, Colitis Ulcerative, Diarrhoea
on Aug 23, 2010 Male patient from UNITED STATES , 27 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Imuran (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), anaemia, colitis ulcerative, diarrhoea. Imuran dosage: . During the same period patient was treated with CIMZIA (400 Mg; 1x Month; Sc) (View Cimzia Review and Cimzia Label ). Patient was hospitalized.


6936810-6 | Abscess, Cholecystectomy, Colectomy, Oophorectomy, Surgery
on Aug 12, 2010 Female patient from UNITED STATES , 33 years of age, was treated with Imuran (View Usage). Patient had the following side effects: abscess (What is abscess?), cholecystectomy, colectomy, oophorectomy, surgery (What is surgery?). Imuran dosage: . Patient was hospitalized.

6936768-X | Acne, Arthralgia, Chronic Gastrointestinal Bleeding, Deep Vein Thrombosis, Fatigue, Intestinal Obstruction, Pneumonia, Pulmonary Embolism
Patient was taking Imuran (View Usage). After Imuran was administered, patient had the following side effects: acne (What is acne?), arthralgia, chronic gastrointestinal bleeding, deep vein thrombosis (What is deep vein thrombosis?), fatigue, intestinal obstruction, pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?) on Aug 04, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Imuran dosage: 150 Mg;. During the same period patient was treated with TYSABRI (300 Mg; Qmon; Iv) (View Tysabri Review and Tysabri Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), PYRIDOXINE HCL (View Pyridoxine Hcl Review and Pyridoxine Hcl Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6932937-3 | Arthralgia, Arthritis, Furuncle, Red Blood Cell Sedimentation Rate Increased, Renal Failure Chronic
Adverse event was reported on Aug 02, 2010 by a Female patient taking Imuran (View Usage) (Dosage: 100 Mg;qd) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , 45 years of age, Patient experienced the following unwanted or unexpected effects: arthralgia, arthritis (What is arthritis?), furuncle, red blood cell sedimentation rate increased, renal failure chronic. During the same period patient was treated with ARAVA (20 Mg; ;po) (View Arava Review and Arava Label ), ETANERCEPT (50 Mg;qw;sc) (View Etanercept Review and Etanercept Label ), CELLCEPT (3 Gm;) (View Cellcept Review and Cellcept Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ACYCLOVIR (1800 Mg;) (View Acyclovir Review and Acyclovir Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), INSULIN (View Insulin Review and Insulin Label ).

6905616-6 | Abscess, Arthralgia, Arthritis, Furuncle, Renal Failure Chronic
on Jul 21, 2010 Female patient from UNITED STATES , 45 years of age, was treated with Imuran (View Usage). Patient had the following side effects: abscess (What is abscess?), arthralgia, arthritis (What is arthritis?), furuncle, renal failure chronic. Imuran dosage: . During the same period patient was treated with ARAVA (Po) (View Arava Review and Arava Label ), ETANERCEPT (50 Mg;qw; Sc) (View Etanercept Review and Etanercept Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ACYCLOVIR (1800 Mg;) (View Acyclovir Review and Acyclovir Label ), METHOTREXATE (CON.) (View Methotrexate (con.) Review and Methotrexate (con.) Label ), INSULIN (CON.) (View Insulin (con.) Review and Insulin (con.) Label ). Patient was hospitalized.

6788717-5 | Activated Partial Thromboplastin Time Prolonged, Asthenia, Catheter Site Haemorrhage, Contusion, Deep Vein Thrombosis, Diastolic Dysfunction, Grip Strength Decreased, Haematoma, Hyperglycaemia
on Jun 11, 2010 Male patient from UNITED STATES , 82 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and was treated with Imuran (View Usage). After Imuran was administered, patient had the following side effects: activated partial thromboplastin time prolonged, asthenia, catheter site haemorrhage, contusion, deep vein thrombosis (What is deep vein thrombosis?), diastolic dysfunction, grip strength decreased, haematoma, hyperglycaemia. Imuran dosage: 25 Mg;qd. During the same period patient was treated with HEPARIN SODIUM INJECTION (5000 Units;q8h;sc) (View Heparin Sodium Injection Review and Heparin Sodium Injection Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ). Patient was hospitalized.

6759986-2 | Collapse Of Lung, Disease Recurrence, Hypertension, Lung Neoplasm Malignant, Neoplasm Skin, Neuralgia, Procedural Complication, Respiratory Tract Infection
Patient was taking Imuran (View Usage). Patient experienced the following unwanted or unexpected effects: collapse of lung, disease recurrence, hypertension, lung neoplasm malignant, neoplasm skin, neuralgia, procedural complication, respiratory tract infection on May 25, 2010 from UNITED STATES Additional patient health information: Female patient , 69 years of age, was diagnosed with arthritis (What is arthritis?), rheumatoid arthritis (What is rheumatoid arthritis?) and. Imuran dosage: 50 Mg Tid Po. During the same period patient was treated with HUMIRA (40 Mg Qow Sc) (View Humira Review and Humira Label ), MICARDIS HCT (View Micardis Hct Review and Micardis Hct Label ), SERETIDE (View Seretide Review and Seretide Label ), PREGABALIN (View Pregabalin Review and Pregabalin Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ), MONTELUKAST (View Montelukast Review and Montelukast Label ).

6739448-9 | Diarrhoea Haemorrhagic
Adverse event was reported on Oct 20, 2009 by a Male patient taking Imuran (View Usage) (Dosage: 75 Mg; Bid) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 54 years of age, Patient had the following side effects: diarrhoea haemorrhagic. During the same period patient was treated with HUMIRA (View Humira Review and Humira Label ), PREDNISONE (CON.) (View Prednisone (con.) Review and Prednisone (con.) Label ). Patient was hospitalized.

6738966-7 | Balanitis, Blood Amylase Decreased, Blood Bicarbonate Increased, Blood Chloride Decreased, Blood Glucose Increased, Blood Triglycerides Increased, Eosinophilia, Haematuria, Lymphocyte Percentage Decreased
on May 13, 2010 Male patient from UNITED STATES , 71 years of age, was diagnosed with idiopathic pulmonary fibrosis and was treated with Imuran (View Usage). After Imuran was administered, patient had the following side effects: balanitis, blood amylase decreased, blood bicarbonate increased, blood chloride decreased, blood glucose increased, blood triglycerides increased, eosinophilia, haematuria, lymphocyte percentage decreased. Imuran dosage: 50 Mg;tid. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), METOLAZONE (View Metolazone Review and Metolazone Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

6718343-5 | Atrial Fibrillation, H1n1 Influenza, Liver Disorder, Myocardial Infarction, Pneumonia Viral
on Apr 21, 2010 Male patient from UNITED STATES , 57 years of age, was diagnosed with colitis ulcerative and was treated with Imuran (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), h1n1 influenza, liver disorder, myocardial infarction, pneumonia viral. Imuran dosage: 50 Mg, Qd;. Patient was hospitalized.

6668942-4 | Malignant Melanoma In Situ
Patient was taking Imuran (View Usage). Patient had the following side effects: malignant melanoma in situ on Mar 25, 2010 from UNITED STATES Additional patient health information: Male patient , 40 years of age, weighting 173.0 lb, was diagnosed with colitis ulcerative, crohn's disease (What is crohn's disease?) and. Imuran dosage: . During the same period patient was treated with HUMIRA (40 Mg; Q2wk) (View Humira Review and Humira Label ), INFLIXIMAB (5 Mg) (View Infliximab Review and Infliximab Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), BALSALAZIDE DISODIUM (View Balsalazide Disodium Review and Balsalazide Disodium Label ), ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), VIGRAN (View Vigran Review and Vigran Label ), CALCIUM CITRATE (View Calcium Citrate Review and Calcium Citrate Label ).

6645057-2 | Blood Amylase Decreased, Blood Bicarbonate Increased, Blood Chloride Decreased, Blood Glucose Increased, Blood Triglycerides Increased, Neutrophil Percentage Increased
Adverse event was reported on Mar 04, 2010 by a Male patient taking Imuran (View Usage) (Dosage: 50 Mg; Tid) was diagnosed with idiopathic pulmonary fibrosis and. Location: UNITED STATES , 71 years of age, After Imuran was administered, patient had the following side effects: blood amylase decreased, blood bicarbonate increased, blood chloride decreased, blood glucose increased, blood triglycerides increased, neutrophil percentage increased. During the same period patient was treated with COUMADIN /00014802/ (CON.) (View Coumadin /00014802/ (con.) Review and Coumadin /00014802/ (con.) Label ), LOSARTAN (CON.) (View Losartan (con.) Review and Losartan (con.) Label ), FUROSEMIDE (CON.) (View Furosemide (con.) Review and Furosemide (con.) Label ), METOLAZONE (CON.) (View Metolazone (con.) Review and Metolazone (con.) Label ), METOPROLOL (CON.) (View Metoprolol (con.) Review and Metoprolol (con.) Label ), GABAPENTIN (CON.) (View Gabapentin (con.) Review and Gabapentin (con.) Label ), AMLODIPINE (CON.) (View Amlodipine (con.) Review and Amlodipine (con.) Label ).

6595273-3 | Anaphylactic Shock
on Feb 02, 2010 Female patient from UNITED STATES , 45 years of age, was diagnosed with autoimmune hepatitis and was treated with Imuran (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock. Imuran dosage: Qd. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6538574-7 | B-cell Lymphoma, Pneumonia
on Jan 13, 2010 Male patient from UNITED STATES , 44 years of age, weighting 298.0 lb, was treated with Imuran (View Usage). Patient had the following side effects: b-cell lymphoma, pneumonia (What is pneumonia?). Imuran dosage: .

6487695-6 | Iatrogenic Injury, Metabolic Acidosis, Renal Failure Acute, Urinary Tract Infection
Patient was taking Imuran (View Usage). After Imuran was administered, patient had the following side effects: iatrogenic injury, metabolic acidosis, renal failure acute, urinary tract infection (What is urinary tract infection?) on Dec 09, 2009 from UNITED STATES Additional patient health information: Male patient , 92 years of age, weighting 130.7 lb, . Imuran dosage: 100mg Daily Po Recent. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), ARICEPT (View Aricept Review and Aricept Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ROPINEROLE (View Ropinerole Review and Ropinerole Label ), ZETIA (View Zetia Review and Zetia Label ), VIT C (View Vit C Review and Vit C Label ). Patient was hospitalized.

6446404-7 | Abasia, Aphasia, Arthralgia, Central Nervous System Lesion, Ingrowing Nail, Mental Disorder, Optic Neuritis, Osteonecrosis, Pain
Adverse event was reported on Nov 09, 2009 by a Male patient taking Imuran (View Usage) (Dosage: ) was diagnosed with relapsing-remitting multiple sclerosis and. Location: UNITED STATES , 50 years of age, Patient experienced the following unwanted or unexpected effects: abasia, aphasia (What is aphasia?), arthralgia, central nervous system lesion, ingrowing nail, mental disorder, optic neuritis, osteonecrosis (What is osteonecrosis?), pain (What is pain?). During the same period patient was treated with SOLU MEDROL (Iv) (View Solu-medrol Review and Solu-medrol Label ), BETASERON (9 Miu; Qod; Sq) (View Betaseron Review and Betaseron Label ). Patient was hospitalized.

6418803-0 | Anaemia Macrocytic, Asthenia, Fatigue, Gout, Leukopenia, Vomiting
on Oct 19, 2009 Male patient from UNITED STATES , 88 years of age, was diagnosed with pemphigoid, gout (What is gout?) and was treated with Imuran (View Usage). Patient had the following side effects: anaemia macrocytic, asthenia, fatigue, gout (What is gout?), leukopenia, vomiting. Imuran dosage: 100 Mg; Qd. During the same period patient was treated with ULORIC (View Uloric Review and Uloric Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), NAMENDA (View Namenda Review and Namenda Label ), COREG (View Coreg Review and Coreg Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TRENTAL (View Trental Review and Trental Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6383199-X | Anaemia Macrocytic, Blood Bicarbonate Decreased, Gout, Leukopenia, Lymphocyte Percentage Decreased, Neutrophil Percentage Decreased, Platelet Count Decreased, Vomiting
on Sep 15, 2009 Male patient from UNITED STATES , 88 years of age, was diagnosed with pemphigoid and was treated with Imuran (View Usage). After Imuran was administered, patient had the following side effects: anaemia macrocytic, blood bicarbonate decreased, gout (What is gout?), leukopenia, lymphocyte percentage decreased, neutrophil percentage decreased, platelet count decreased, vomiting. Imuran dosage: 100 Mg;qd;. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), BACTRIM (View Bactrim Review and Bactrim Label ), NAMENDA (View Namenda Review and Namenda Label ), COREG (View Coreg Review and Coreg Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TRENTAL (View Trental Review and Trental Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DUCUSATE (View Ducusate Review and Ducusate Label ). Patient was hospitalized.

6367664-7 | Acute Respiratory Failure, Aphasia, B-lymphocyte Count Increased, Brain Herniation, Brain Mass, Brain Oedema, Confusional State, Cough, Dysarthria
Patient was taking Imuran (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure, aphasia (What is aphasia?), b-lymphocyte count increased, brain herniation, brain mass, brain oedema, confusional state, cough, dysarthria on Sep 04, 2009 from UNITED STATES Additional patient health information: Female patient , 69 years of age, was diagnosed with autoimmune hepatitis and. Imuran dosage: 50 Mg; Qd;. Patient was hospitalized.

6354326-5 | Anaemia, Blood Uric Acid Increased, Bone Marrow Failure, Bone Pain, Pain In Extremity, Product Substitution Issue, Pyrexia, Renal Disorder
Adverse event was reported on Aug 26, 2009 by a Male patient taking Imuran (View Usage) (Dosage: 150 Mg;qd;) was diagnosed with immunosuppression, prophylaxis against transplant rejection and. Location: UNITED STATES , 51 years of age, Patient had the following side effects: anaemia, blood uric acid increased, bone marrow failure, bone pain, pain in extremity, product substitution issue, pyrexia, renal disorder. During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), NORVASC (View Norvasc Review and Norvasc Label ), ZETIA (View Zetia Review and Zetia Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), COREG (View Coreg Review and Coreg Label ), CARDURA /00639301/ (View Cardura /00639301/ Review and Cardura /00639301/ Label ). Patient was hospitalized.

6299404-4 | Anaemia Vitamin B12 Deficiency, Bk Virus Infection, Clostridial Infection, Complications Of Transplanted Kidney, Culture Stool Positive, Dialysis, Diarrhoea, Encephalopathy, Failure To Thrive
on Jul 22, 2009 Male patient from UNITED STATES , 72 years of age, was diagnosed with renal disorder, antiviral prophylaxis, antifungal prophylaxis and was treated with Imuran (View Usage). After Imuran was administered, patient had the following side effects: anaemia vitamin b12 deficiency, bk virus infection, clostridial infection, complications of transplanted kidney, culture stool positive, dialysis (What is dialysis?), diarrhoea, encephalopathy, failure to thrive. Imuran dosage: 100 Mg; Po. During the same period patient was treated with VALCYTE (900 Mg; Po) (View Valcyte Review and Valcyte Label ), SEPTRA DS (1 Tab; Po) (View Septra Ds Review and Septra Ds Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MESALMINE (View Mesalmine Review and Mesalmine Label ), TERAZOSIN HYDROCHLORIDE (View Terazosin Hydrochloride Review and Terazosin Hydrochloride Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), LANTHANUM CARBONATE (View Lanthanum Carbonate Review and Lanthanum Carbonate Label ). Patient was hospitalized.

6284077-7 | Breast Cancer
on Jul 14, 2009 Female patient from UNITED STATES , 39 years of age, weighting 135.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Imuran (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Imuran dosage: 50 Mg; Qd;. During the same period patient was treated with REMICADE (7.5 Mg/kg; Q6-8wks; Iv) (View Remicade Review and Remicade Label ), ASACOL (View Asacol Review and Asacol Label ), ZANTAC /00550802/ (View Zantac /00550802/ Review and Zantac /00550802/ Label ), FOLATE (View Folate Review and Folate Label ).

6272503-9 | Diarrhoea, Malaise, Nausea
Patient was taking Imuran (View Usage). Patient had the following side effects: diarrhoea, malaise, nausea (What is nausea?) on Jul 16, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 278.0 lb, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Imuran dosage: One A Day.

6245035-1 | Pancreatitis
Adverse event was reported on Jan 23, 2009 by a Male patient taking Imuran (View Usage) (Dosage: 200 Mg;qd) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 38 years of age, weighting 200.6 lb, After Imuran was administered, patient had the following side effects: pancreatitis. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NEXIUM (View Nexium Review and Nexium Label ), SLOW FE (View Slow Fe Review and Slow Fe Label ), IMODIUM (View Imodium Review and Imodium Label ), BENADRYL (View Benadryl Review and Benadryl Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ). Patient was hospitalized.

6245029-6 | Pancreatitis
on Jan 23, 2009 Female patient from UNITED STATES , 52 years of age, weighting 177.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Imuran (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis. Imuran dosage: 2.5 Mg/kg;qd;po. During the same period patient was treated with AZATHIOPRINE (2.5 Mg/kg;qd;po) (View Azathioprine Review and Azathioprine Label ), INFLIXIMAB, RECOMBINANT (INFLIXIMAB, RECOMBINANT) LYOPHILIZED POWDER (400 Mg;qd;iv) (View Infliximab, Recombinant (infliximab, Recombinant) Lyophilized Powder Review and Infliximab, Recombinant (infliximab, Recombinant) Lyophilized Powder Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ACTIFED /00005601/ (View Actifed /00005601/ Review and Actifed /00005601/ Label ), CENTRUM SILVER /01292501/ (View Centrum Silver /01292501/ Review and Centrum Silver /01292501/ Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), IMODIUM A D (View Imodium A-d Review and Imodium A-d Label ), PEPCID AC (View Pepcid Ac Review and Pepcid Ac Label ). Patient was hospitalized.

6244275-5 | Arthralgia, Pancreatitis
on Apr 15, 2008 Female patient from UNITED STATES , 63 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Imuran (View Usage). Patient had the following side effects: arthralgia, pancreatitis. Imuran dosage: 100 Mg;po. Patient was hospitalized.

6244258-5 | Crohn's Disease, Pancreatitis Acute
Patient was taking Imuran (View Usage). After Imuran was administered, patient had the following side effects: crohn's disease (What is crohn's disease?), pancreatitis acute on Jan 20, 2009 from UNITED STATES Additional patient health information: Female patient , 41 years of age, weighting 248.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Imuran dosage: 250 Mg;qd;po. During the same period patient was treated with MESALAMINE (View Mesalamine Review and Mesalamine Label ), SERTRALINE (View Sertraline Review and Sertraline Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), DONNATAL (View Donnatal Review and Donnatal Label ), CRYSELLE (View Cryselle Review and Cryselle Label ), PROPACET 100 (View Propacet 100 Review and Propacet 100 Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.

6244245-7 | Pancreatitis
Adverse event was reported on Jan 20, 2009 by a Male patient taking Imuran (View Usage) (Dosage: 2.5 Mg/kg;qd;po) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 36 years of age, weighting 236.0 lb, Patient experienced the following unwanted or unexpected effects: pancreatitis. During the same period patient was treated with COLAZAL (View Colazal Review and Colazal Label ). Patient was hospitalized.

6171276-8 | Abdominal Pain, Hepatic Enzyme Increased
on Apr 28, 2009 Female patient from UNITED STATES , 57 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Imuran (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), hepatic enzyme increased. Imuran dosage: . During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ), CRESTOR (View Crestor Review and Crestor Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), EVOXAC (View Evoxac Review and Evoxac Label ), LOTREL (View Lotrel Review and Lotrel Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), METROGEL (View Metrogel Review and Metrogel Label ), NASONEX (View Nasonex Review and Nasonex Label ). Patient was hospitalized.

6129969-4 | Neoplasm Malignant, Virilism
on Mar 23, 2009 Female patient from UNITED STATES , 41 years of age, weighting 142.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Imuran (View Usage). After Imuran was administered, patient had the following side effects: neoplasm malignant, virilism. Imuran dosage: 150mg Every Day Po. During the same period patient was treated with ENTOCORT 3MG (9mg Every Day Po) (View Entocort 3mg Review and Entocort 3mg Label ).

6087535-3 | Haemodialysis, Hypoxia, Leukopenia, Lymphocyte Count Decreased, Mucous Membrane Disorder, Rash, Respiratory Distress
Patient was taking Imuran (View Usage). Patient experienced the following unwanted or unexpected effects: haemodialysis, hypoxia, leukopenia, lymphocyte count decreased, mucous membrane disorder, rash (What is rash?), respiratory distress on Feb 03, 2009 from UNITED STATES Additional patient health information: Male patient , 64 years of age, . Imuran dosage: 100 Mg; Qd;. Patient was hospitalized.

6067789-X | Granulocyte Count Increased, Small Intestinal Obstruction, Vascular Calcification
Adverse event was reported on Jan 23, 2009 by a Male patient taking Imuran (View Usage) (Dosage: 2.5 Mg/kg; Qd) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 30 years of age, weighting 292.0 lb, Patient had the following side effects: granulocyte count increased, small intestinal obstruction, vascular calcification. During the same period patient was treated with AZATHIOPRINE (2.5 Mg/kg;qd) (View Azathioprine Review and Azathioprine Label ), INFLIXIMAB, RECOMBINANT (5mg/kg/qd; Iv) (View Infliximab, Recombinant Review and Infliximab, Recombinant Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

6065751-4 | Abdominal Pain Upper, Dehydration, Duodenitis, Fatigue, Gastritis, Haematemesis, Haematochezia, Hypersomnia
on Jan 20, 2009 Female patient from UNITED STATES , 21 years of age, weighting 138.9 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Imuran (View Usage). After Imuran was administered, patient had the following side effects: abdominal pain upper, dehydration, duodenitis, fatigue, gastritis, haematemesis, haematochezia, hypersomnia. Imuran dosage: 2.5 Mg/kg/qd/po. During the same period patient was treated with AZATHIOPRINE (INFLIXIMAB, RECOMBINANT COMPARATOR) TABLET (2.5 Mg/kg;qd;po) (View Azathioprine (infliximab, Recombinant Comparator) Tablet Review and Azathioprine (infliximab, Recombinant Comparator) Tablet Label ), ASACOL (View Asacol Review and Asacol Label ), ORTHO TRI CYCLEN (View Ortho Tri-cyclen Review and Ortho Tri-cyclen Label ). Patient was hospitalized.

6029322-8 | Aphasia, Cerebrovascular Accident, Hemiparesis, Progressive Multifocal Leukoencephalopathy, Status Epilepticus
on Dec 16, 2008 Male patient from UNITED STATES , 68 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Imuran (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), cerebrovascular accident, hemiparesis, progressive multifocal leukoencephalopathy, status epilepticus. Imuran dosage: . During the same period patient was treated with LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ), CYTOSIDE ARABINOSIDE (View Cytoside Arabinoside Review and Cytoside Arabinoside Label ), PHENYTOIN SODIUM (View Phenytoin Sodium Review and Phenytoin Sodium Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ). Patient was hospitalized.

6012754-1 | Eosinophilic Pneumonia, Interstitial Lung Disease
Patient was taking Imuran (View Usage). Patient had the following side effects: eosinophilic pneumonia, interstitial lung disease on Dec 01, 2008 from UNITED STATES Additional patient health information: Female patient , 63 years of age, was diagnosed with colitis ulcerative and. Imuran dosage: . During the same period patient was treated with INFLIXIMAB (Qm; Iv) (View Infliximab Review and Infliximab Label ), BALSALAZIDE DISODIUM (View Balsalazide Disodium Review and Balsalazide Disodium Label ), HYDROCORTISONE ENEMA (View Hydrocortisone Enema Review and Hydrocortisone Enema Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), IBANDRONATE SODIUM (View Ibandronate Sodium Review and Ibandronate Sodium Label ), CONJUGATED ESTROGENS (View Conjugated Estrogens Review and Conjugated Estrogens Label ). Patient was hospitalized.

5990499-1 | Anorexia, Fatigue, Flatulence, Ill-defined Disorder, Liver Function Test Abnormal, Middle Insomnia
Adverse event was reported on Nov 24, 2008 by a Male patient taking Imuran (View Usage) (Dosage: 125 Mg) was diagnosed with prophylaxis, colitis ulcerative and. Location: UNITED STATES , 67 years of age, weighting 204.0 lb, After Imuran was administered, patient had the following side effects: anorexia, fatigue, flatulence, ill-defined disorder, liver function test abnormal, middle insomnia. During the same period patient was treated with REMICADE (Iv) (View Remicade Review and Remicade Label ).

5971926-2 | Basal Cell Carcinoma
on Nov 10, 2008 Male patient from UNITED STATES , 35 years of age, was treated with Imuran (View Usage). Patient experienced the following unwanted or unexpected effects: basal cell carcinoma. Imuran dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

5961306-8 | Febrile Neutropenia, Human Herpesvirus 8 Infection, Kaposi's Sarcoma, Multi-organ Failure, Pancytopenia, Sepsis
on Sep 30, 2008 Male patient from UNITED STATES , 44 years of age, was treated with Imuran (View Usage). Patient had the following side effects: febrile neutropenia, human herpesvirus 8 infection, kaposi's sarcoma (What is kaposi's sarcoma?), multi-organ failure, pancytopenia, sepsis (What is sepsis?). Imuran dosage: Po. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PLEURAL EFFUSION (View Pleural Effusion Review and Pleural Effusion Label ), BRONCHIAL HAEMORRHAGE (View Bronchial Haemorrhage Review and Bronchial Haemorrhage Label ), DYSPNOEA (View Dyspnoea Review and Dyspnoea Label ), FEBRILE NEUTROPENIA (View Febrile Neutropenia Review and Febrile Neutropenia Label ), SEPSIS (View Sepsis Review and Sepsis Label ). Patient was hospitalized.

5960961-6 | Anaemia, Ascites, Colonoscopy Abnormal, Diarrhoea, Failure To Thrive, Kaposi's Sarcoma, Lung Neoplasm, Pancytopenia, Renal Failure Acute
Patient was taking Imuran (View Usage). After Imuran was administered, patient had the following side effects: anaemia, ascites, colonoscopy abnormal, diarrhoea, failure to thrive, kaposi's sarcoma (What is kaposi's sarcoma?), lung neoplasm, pancytopenia, renal failure acute on Sep 30, 2008 from UNITED STATES Additional patient health information: Male patient , 48 years of age, . Imuran dosage: Po. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), SIROLIMUS (View Sirolimus Review and Sirolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ). Patient was hospitalized.

5948680-3 | Abdominal Pain, Acute Respiratory Distress Syndrome, Anaemia, Anorexia, Blood Triglycerides Increased, Chromaturia, Diarrhoea Haemorrhagic, Epstein-barr Virus Infection, Hepatitis
Adverse event was reported on Oct 22, 2008 by a Female patient taking Imuran (View Usage) (Dosage: 125 Mg;) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 18 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), acute respiratory distress syndrome, anaemia, anorexia, blood triglycerides increased, chromaturia, diarrhoea haemorrhagic, epstein-barr virus infection, hepatitis (What is hepatitis?). During the same period patient was treated with INFLIXIMAB (View Infliximab Review and Infliximab Label ). Patient was hospitalized.

5942240-6 | Acute Febrile Neutrophilic Dermatosis
on Oct 16, 2008 Male patient from UNITED STATES , 42 years of age, was diagnosed with colitis ulcerative and was treated with Imuran (View Usage). Patient had the following side effects: acute febrile neutrophilic dermatosis. Imuran dosage: 50 Mg; Qd;. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

5942238-8 | Abscess, Acute Febrile Neutrophilic Dermatosis, Back Pain, C-reactive Protein Increased, Chills, Condition Aggravated, Erythema, Eyelid Ptosis, Induration
on Oct 16, 2008 Male patient from UNITED STATES , 68 years of age, was diagnosed with myasthenia gravis and was treated with Imuran (View Usage). After Imuran was administered, patient had the following side effects: abscess (What is abscess?), acute febrile neutrophilic dermatosis, back pain (What is back pain?), c-reactive protein increased, chills, condition aggravated, erythema, eyelid ptosis, induration. Imuran dosage: 50 Mg; Qd;. During the same period patient was treated with PYRIDOSTIGMINE BROMIDE (View Pyridostigmine Bromide Review and Pyridostigmine Bromide Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

5941993-0 | Arrhythmia, Atrial Flutter, Bronchopulmonary Aspergillosis, Cardiac Arrest, Pneumonia Streptococcal, Respiratory Failure
Patient was taking Imuran (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), atrial flutter, bronchopulmonary aspergillosis, cardiac arrest (What is cardiac arrest?), pneumonia streptococcal, respiratory failure on Oct 17, 2008 from UNITED STATES Additional patient health information: Male patient , 78 years of age, was diagnosed with immunosuppression and. Imuran dosage: 150 Mg;qd;po. During the same period patient was treated with PREDNISONE TAB (40 Mg;qd;po) (View Prednisone Tab Review and Prednisone Tab Label ), PERCOCET (View Percocet Review and Percocet Label ), LIDODERM (View Lidoderm Review and Lidoderm Label ), IBUPROFEN TABLETS (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ), CARAFATE (View Carafate Review and Carafate Label ), ECHINACEA (View Echinacea Review and Echinacea Label ), NASONEX (View Nasonex Review and Nasonex Label ), PROTONIX (View Protonix Review and Protonix Label ). Patient was hospitalized.

5939628-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Dizziness, Hepatotoxicity, Liver Injury, Rash
Adverse event was reported on Oct 30, 2008 by a Female patient taking Imuran (View Usage) (Dosage: ) . Location: UNITED STATES , 34 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, dizziness (What is dizziness?), hepatotoxicity, liver injury, rash (What is rash?). During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), FLAGYL (View Flagyl Review and Flagyl Label ), TYLENOL W/ CODEINE (View Tylenol W/ Codeine Review and Tylenol W/ Codeine Label ), ACTIGALL (View Actigall Review and Actigall Label ). Patient was hospitalized.

5939501-3 | Acute Febrile Neutrophilic Dermatosis, Arthralgia, Cellulitis, Oedema Peripheral, White Blood Cell Count Increased
on Oct 16, 2008 Male patient from UNITED STATES , 32 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Imuran (View Usage). After Imuran was administered, patient had the following side effects: acute febrile neutrophilic dermatosis, arthralgia, cellulitis (What is cellulitis?), oedema peripheral, white blood cell count increased. Imuran dosage: 100 Mg; Qd. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), CEFAZOLIN SODIUM (View Cefazolin Sodium Review and Cefazolin Sodium Label ), CEFEPIME HYDRCHLORIDE4 (View Cefepime Hydrchloride4 Review and Cefepime Hydrchloride4 Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

5939500-1 | Human Herpesvirus 8 Infection, Kaposi's Sarcoma, Performance Status Decreased, Transmission Of An Infectious Agent Via A Medicinal Product
on Sep 24, 2008 Male patient from UNITED STATES , 49 years of age, was diagnosed with immunosuppression and was treated with Imuran (View Usage). Patient experienced the following unwanted or unexpected effects: human herpesvirus 8 infection, kaposi's sarcoma (What is kaposi's sarcoma?), performance status decreased, transmission of an infectious agent via a medicinal product. Imuran dosage: . During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), TAROLIMUS (View Tarolimus Review and Tarolimus Label ).

5918255-0 | Disease Progression, Hepatic Cirrhosis, Hepatic Neoplasm Malignant, Liver Transplant, Precancerous Cells Present, Viral Infection
Patient was taking Imuran (View Usage). Patient had the following side effects: disease progression, hepatic cirrhosis, hepatic neoplasm malignant, liver transplant (What is liver transplant?), precancerous cells present, viral infection (What is viral infection?) on Apr 08, 2008 from UNITED STATES Additional patient health information: Female patient , 44 years of age, . Imuran dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.